Bank of Montreal
LOGC

Bank of Montreal’s LogicBio Therapeutics, Inc. Common Stock LOGC Stock Holding History

Bank of Montreal’s Portfolio LOGC Stock Details LOGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,726
Closed -$11K – 5333
2021
Q1 		$11K Sell
1,726
-2,071
-55% -$17K ﹤0.01% 4353
2020
Q4 		$32K Buy
3,797
+1,818
+92% +$12.2K ﹤0.01% 4192
2020
Q3 		$14K Sell
1,979
-173
-8% -$1.31K ﹤0.01% 4002
2020
Q2 		$16K Buy
+2,152
New +$14.2K ﹤0.01% 3963
2020
Q1 		– Sell
-1,093
Closed -$8K – 4921
2019
Q4 		$8K Buy
1,093
+373
+52% +$3.37K ﹤0.01% 4629
2019
Q3 		$8K Buy
720
+28
+4% +$300 ﹤0.01% 4491
2019
Q2 		$9K Buy
+692
New +$9.19K ﹤0.01% 4578

Other funds holding LOGC

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Bank of Montreal's LOGC Position: Q2 2021 in Review

Bank of Montreal sold out of LogicBio Therapeutics, Inc. Common Stock (LOGC) in Q2 2021, closing a stake of 1,726 shares — an estimated $11K sold.

Bank of Montreal first reported a position in LOGC in Q2 2019 and held it in 7 quarters. The position peaked at $32K in Q4 2020. 63 funds tracked by Wall St. Rank hold LOGC as of Q2 2021.

  • Bank of Montreal reported no remaining LogicBio Therapeutics, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 1,726 LogicBio Therapeutics, Inc. Common Stock shares in Q2 2021, an estimated $11K.
  • Bank of Montreal first reported a position in LogicBio Therapeutics, Inc. Common Stock in Q2 2019 and held it in 7 quarters.
  • Bank of Montreal's LogicBio Therapeutics, Inc. Common Stock position peaked at $32K in Q4 2020.
  • 63 funds tracked by Wall St. Rank held LogicBio Therapeutics, Inc. Common Stock as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.